- Home
- MAV vs OABI Comparison
MAV vs OABI Comparison
Compare MAV & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAV
- OABI
- Stock Information
- Founded
- MAV 2003
- OABI 2012
- Country
- MAV United States
- OABI United States
- Employees
- MAV N/A
- OABI N/A
- Industry
- MAV Finance Companies
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- MAV Finance
- OABI Health Care
- Exchange
- MAV Nasdaq
- OABI Nasdaq
- Market Cap
- MAV 199.0M
- OABI 198.2M
- IPO Year
- MAV N/A
- OABI N/A
- Fundamental
- Price
- MAV $8.28
- OABI $1.66
- Analyst Decision
- MAV
- OABI Strong Buy
- Analyst Count
- MAV 0
- OABI 3
- Target Price
- MAV N/A
- OABI $7.00
- AVG Volume (30 Days)
- MAV 66.2K
- OABI 1.1M
- Earning Date
- MAV 01-01-0001
- OABI 08-07-2025
- Dividend Yield
- MAV 4.30%
- OABI N/A
- EPS Growth
- MAV N/A
- OABI N/A
- EPS
- MAV N/A
- OABI N/A
- Revenue
- MAV N/A
- OABI $26,744,000.00
- Revenue This Year
- MAV N/A
- OABI N/A
- Revenue Next Year
- MAV N/A
- OABI $45.65
- P/E Ratio
- MAV N/A
- OABI N/A
- Revenue Growth
- MAV N/A
- OABI 27.07
- 52 Week Low
- MAV $6.37
- OABI $1.22
- 52 Week High
- MAV $8.34
- OABI $4.96
- Technical
- Relative Strength Index (RSI)
- MAV 50.70
- OABI 53.98
- Support Level
- MAV $8.22
- OABI $1.55
- Resistance Level
- MAV $8.34
- OABI $1.73
- Average True Range (ATR)
- MAV 0.06
- OABI 0.11
- MACD
- MAV -0.00
- OABI 0.02
- Stochastic Oscillator
- MAV 50.00
- OABI 68.13
About MAV Pioneer Municipal High Income Advantage Fund Inc.
Pioneer Muni High Income Advantage Tr is a closed-end fund designed to pursue high current income exempt from regular federal income tax, and as a secondary objective, to seek capital appreciation. It predominantly invests in debt securities and other obligations issued by or on behalf of states, territories, and possessions of the United States and the District of Columbia and their political subdivisions, agencies, and instrumentalities, the interest on which is exempt from regular federal income tax.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.